Aflac Incorporated (NYSE:AFL – Get Free Report) Director Joseph Moskowitz sold 600 shares of the firm’s stock in a transaction that occurred on Monday, August 10th. The shares were sold at an average price of $124.10, for a total value of $74,460.00. Following the completion of the sale, the director owned 32,710 shares in the company, valued at approximately $4,059,311. This represents a 1.80% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Aflac Trading Down 0.4%
NYSE:AFL opened at $120.62 on Thursday. The stock has a market cap of $60.47 billion, a price-to-earnings ratio of 12.93, a PEG ratio of 1.95 and a beta of 0.60. The company has a debt-to-equity ratio of 0.29, a quick ratio of 0.11 and a current ratio of 0.12. Aflac Incorporated has a 1 year low of $103.80 and a 1 year high of $130.22. The business has a fifty day moving average of $121.18 and a 200-day moving average of $115.68.
Aflac (NYSE:AFL – Get Free Report) last posted its quarterly earnings data on Thursday, August 6th. The financial services provider reported $1.75 earnings per share for the quarter, missing the consensus estimate of $1.76 by ($0.01). The company had revenue of $4.22 billion during the quarter, compared to analyst estimates of $4.11 billion. Aflac had a return on equity of 13.27% and a net margin of 26.91%.The business’s revenue for the quarter was down 1.0% compared to the same quarter last year. During the same period in the previous year, the company earned $1.78 EPS. Equities analysts predict that Aflac Incorporated will post 7.05 earnings per share for the current year.
Aflac Announces Dividend
Aflac News Roundup
Here are the key news stories impacting Aflac this week:
- Positive Sentiment: Keefe, Bruyette & Woods raised its price target to $125 from $120 while maintaining a “market perform” rating, indicating limited but improved upside potential. Benzinga analyst rating update
- Positive Sentiment: Accident and health insurers, including Aflac, could benefit from increased underwriting exposure and greater digitalization. However, rising medical costs and inflation may pressure pricing. Zacks accident and health insurers outlook
- Neutral Sentiment: Wells Fargo kept a “hold” rating and a $120 price target, citing Aflac’s solid sector positioning but modest growth prospects and questions around mergers-and-acquisitions capital allocation. Wells Fargo Aflac rating
- Neutral Sentiment: Director Joseph L. Moskowitz sold 600 shares worth approximately $74,460 under a pre-arranged Rule 10b5-1 trading plan. The sale reduced his position by 1.8%, making it a limited insider-selling signal. Aflac insider transaction filing
- Negative Sentiment: JPMorgan lowered its price target to $116 from $117 and retained a “neutral” rating, implying downside from the referenced trading level. JPMorgan analyst rating update
- Negative Sentiment: Dowling & Partners cut its fiscal 2026 earnings-per-share estimate to $7.00 from $7.05, adding pressure after Aflac’s latest quarter slightly missed consensus EPS expectations and revenue declined year over year. Aflac earnings information
Institutional Trading of Aflac
Institutional investors have recently added to or reduced their stakes in the business. Stephens Inc. AR increased its stake in shares of Aflac by 0.4% in the 4th quarter. Stephens Inc. AR now owns 21,945 shares of the financial services provider’s stock worth $2,420,000 after acquiring an additional 91 shares during the last quarter. Compound Planning Inc. grew its holdings in shares of Aflac by 0.7% in the first quarter. Compound Planning Inc. now owns 13,743 shares of the financial services provider’s stock valued at $1,508,000 after purchasing an additional 91 shares during the period. Root Financial Partners LLC grew its holdings in shares of Aflac by 4.5% in the fourth quarter. Root Financial Partners LLC now owns 2,119 shares of the financial services provider’s stock valued at $234,000 after purchasing an additional 92 shares during the period. CENTRAL TRUST Co increased its position in Aflac by 0.5% during the fourth quarter. CENTRAL TRUST Co now owns 19,088 shares of the financial services provider’s stock worth $2,105,000 after purchasing an additional 95 shares during the last quarter. Finally, HBK Sorce Advisory LLC increased its position in Aflac by 1.2% during the fourth quarter. HBK Sorce Advisory LLC now owns 7,702 shares of the financial services provider’s stock worth $902,000 after purchasing an additional 95 shares during the last quarter. 67.44% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
A number of research analysts recently commented on AFL shares. Barclays reaffirmed an “underweight” rating and set a $99.00 price objective (up from $98.00) on shares of Aflac in a research report on Friday, August 7th. TD Cowen restated a “hold” rating and set a $110.00 price target (up from $101.00) on shares of Aflac in a report on Wednesday, July 22nd. Wall Street Zen raised shares of Aflac from a “sell” rating to a “hold” rating in a research note on Saturday, May 9th. Mizuho set a $116.00 price objective on Aflac in a report on Monday. Finally, Morgan Stanley lifted their price objective on Aflac from $120.00 to $125.00 and gave the company an “equal weight” rating in a research report on Thursday, May 21st. One research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating, seven have assigned a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $117.58.
Check Out Our Latest Research Report on Aflac
About Aflac
Aflac Incorporated (American Family Life Assurance Company of Columbus) is a provider of supplemental insurance products designed to help policyholders manage out-of-pocket health care and living expenses. The company underwrites a range of individual and group policies that typically pay cash benefits directly to insureds when covered events occur, enabling greater financial flexibility for medical treatment, hospital stays, critical illness, and related costs. Aflac’s product mix includes supplemental health insurance, life insurance and other specialty coverages intended to complement primary medical plans.
Founded in the mid-20th century and headquartered in Columbus, Georgia, Aflac distributes its products through a combination of employer-sponsored programs, independent brokers and agents, and direct marketing.
Read More
- Five stocks we like better than Aflac
- Franco-Nevada Earnings: Gold Is Rallying, But Does the Stock Even Care?
- GE Vernova’s AI Power Boom Faces a Profit Test
- Cardinal Health Earnings: Can Perfection Get Priced In Twice?
- Nebius’ Q2 Beat Shows the AI Bottleneck Is Capacity, Not Demand
Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.
